Cancer and other medicines: Track our progress to funding

Following the budget injection from the Government, we're moving fast to fund the medicines on our Options for Investment list.

On this page

About this page

This page lists the treatments that we have been able to progress because of the 2024 budget increase. 

We will add treatments to this page as we announce them. We cannot give information on which applications are coming next. We need to maintain secrecy while we are negotiating with pharmaceutical companies.

You can check our complete options for investment list(external link), which has every application that we would like to fund. 

Summary

Status Cancer medicines Non-cancer medicines Total
Funded 7 12 19
Considering feedback 13 6 19
Consultation open 0 0 0
Total 20 18 38

We have also requested tenders to supply bevacizumab to treat multiple cancers

Funded cancer medicines

Funded non-cancer medicines

Our funding boost is allowing Pharmac to fund many of the high-priority medicines that are high on our options for investment list. Funding these medicines helps address many conditions with a high health need.

Cancer medicines we're working on

Non-cancer medicines we're working on

Other procurement that we're working on

Pharmac has issued a 'request for tenders' for bevacizumab to treat various cancers. We are asking suppliers to give us their best bids to meet our goals.

Request for tenders (RFT): Supply of bevacizumab

Media release: Making more new cancer treatments available for New Zealanders

Application Tracker | Funding applications for bevacizumab(external link)

We signaled this request for tenders in August 2024.

Media release: Pharmac indicates interest in funding cancer treatment bevacizumab

About future procurement opportunities

Who to contact

If you have questions about any of the items on this page, email enquiry@pharmac.govt.nz